iSpeak Blog
Globally, there is an increase in approved advanced therapy medicinal products (ATMPs), with thousands of therapies currently in various stages of pre-clinical and clinical development.
Ryan Paul Mazur
Genesis AEC
Process Engineer II
Ryan Mazur has over two years of experience of process engineering experience in the design of biotech, sterile fill / finish, and wastewater treatment facilities. Ryan has successfully driven integrated projects from conceptual design through detailed design, construction admin, and CQV. Ryan has reviewed pipe specifications, technical bids, equipment specifications, and P&IDs for a project that was recognized as a ISPE FOYA category winner for Innovation in 2022. Ryan has also served as a system lead for high-speed filling lines, where he has drafted BFDs and URS’ alongside navigating the completion of a mock-up protocol and risk assessment virtually with a vendor. His main tasks include development of PFDs, P&IDs, cGMP equipment sizing and specification, hydraulic calculations, pressure relief valve and vessel relief scenarios and calculations, and process modeling. Ryan’s strength as a process engineer lies in his tenacity for continuous technical education and professional development alongside his strong communication skills to clearly define a client’s needs and expectations.
Related Articles
iSpeak Blog
As with all aspects of our life sciences industry, understanding how we can best meet the needs of patients with the timely delivery of life saving and sustaining products is of paramount concern. During the years since the global pandemic, the expectations and pressures on the pharmaceutical industry with respect to development, speed to market, quality and sustainability have increased...
iSpeak Blog
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
iSpeak Blog
In the wake of the COVID-19 pandemic, the landscape of cell and gene therapy (CGT) manufacturing has witnessed significant transformation. The industry has seen an increased emphasis on the advantages of advanced therapy medicinal products (ATMPs) and the push for increases in manufacturing scale and overall availability to larger populations. ATMPs find themselves at a critical juncture where...
iSpeak Blog
Building off of the success of the 2022 ISPE Annual Meeting & Expo, the 2023 ISPE Annual Meeting & Expo Program Committee has developed a robust Workshop program covering key areas in Digital Transformation (DT) and Pharma 4.0™, Quality Risk Management (QRM), Contamination Control Strategy (CCS) and Annex 1, Facility...
iSpeak Blog
Building off of the success of the 2022 ISPE Aseptic Conference, the program committee has developed a robust program covering key areas in aseptic manufacturing, processing, and filling for students, emerging...